News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|March 29, 2016

Treating Glioblastoma

Advertisement
Your browser does not support the video tag.

Episodes in this series

EP. 1 What is Glioblastoma?
EP. 1 What is Glioblastoma?
EP. 2 Treating Glioblastoma
Now Playing
EP. 2 Treating Glioblastoma
EP. 3 What To Know About The Optune Device
EP. 3 What To Know About The Optune Device

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Image of Brain.

FDA Grants Exousia Pro Orphan Drug Designation in Glioma

ByAlex Biese
October 29th 2025
Image of people.

What Dermatological Side Effects Can Patients With Breast Cancer Expect?

ByAlex Biese
October 28th 2025
Image of brain.

FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

BySpencer Feldman
October 27th 2025
brain cancer

FDA Fast Tracks MT-125 for Glioblastoma

ByAlex Biese
October 24th 2025
In patients with operable, newly diagnosed brain metastases, GammaTile was associated with reduction in the risk of tumor recurrence or death.

GammaTile May Reduce Risk of Brain Tumor Recurrence or Death

ByAlex Biese
October 21st 2025
Advertisement
Advertisement

Trending on CURE

1

What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?

2

Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship

3

SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education

4

Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.